Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294488 · ClinicalTrials.gov registry record · Phase 2
Using Technology to Augment the Implementation and Effectiveness of PCIT
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 317
- Enrollment target
NCT01294488: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT01294488 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 317 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (138% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01294488, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 317 participants
- Enrollment target
Study Summary
The overarching aim of the proposed study is to test the implementation effectiveness of two implementation approaches-Remote Real-Time (RRT) using the internet telemedicine technology and traditional Phone Consultation (PC) for training practitioners in PCIT. The study will add to emerging knowledge about how technology can facilitate the transport of evidence-based intervention models into field settings.
Interventions
- BEHAVIORAL Parent-Child Interaction Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
What the finished NCT01294488 record still lists
NCT01294488 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (138% higher).
The record links to 0 conditions, and to 1 intervention - of which Parent-Child Interaction Therapy is the first listed.
NCT01294488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01294488 about?
NCT01294488 is a clinical study titled "Using Technology to Augment the Implementation and Effectiveness of PCIT". The overarching aim of the proposed study is to test the implementation effectiveness of two implementation approaches-Remote Real-Time (RRT) using the internet telemedicine technology and traditional Phone Consultation (PC) for training practitioners in PCIT. The study will add to emerging knowledg...
What is the current status of trial NCT01294488?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 317 participants. The study started on 2007-01. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01294488?
The interventions under investigation include: Parent-Child Interaction Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01294488?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01294488's enrollment target sits among peer trials
317 155th of 2000 higher than 1,846 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia